We are live on !
Find out more
Stance Capital Portfolio holdings
AUM
$328M
Turnover
54.46%
1-Year Est. Return
48.17%
This Fund
S&P 500
This Quarter Est. Return
+31.52%
1 Year Est. Return
+48.17%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$328M
AUM Growth
+$122M
(+59%)
Cap. Flow
+$83.8M
Cap. Flow % of AUM
Cap. Flow %
25.52%
Top 10 Holdings %
Top 10 Hldgs %
22.4%
Holding
426
New
146
Increased
72
Reduced
74
Closed
86
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rollins
ROL
|
+$4.54M |
| 2 |
Comcast
CMCSA
|
+$3.72M |
| 3 |
Applied Materials
AMAT
|
+$3.67M |
| 4 |
Gilead Sciences
GILD
|
+$3.5M |
| 5 |
Intel
INTC
|
+$3.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$4.36M |
| 2 |
Western Digital
WDC
|
+$3.74M |
| 3 |
Viatris
VTRS
|
+$3.61M |
| 4 |
eBay
EBAY
|
+$3.6M |
| 5 |
HP
HPQ
|
+$3.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Consumer Discretionary | 12.31% |
| 3 | Healthcare | 10.12% |
| 4 | Industrials | 9.85% |
| 5 | Financials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
GE HealthCare
GEHC
$37B
| $25.5K | 0.01% |
399
-1
| -0.3% | -$66 |
2026 Q1
1 quarter
|
|
202
Equity Lifestyle Properties
ELS
$12B
| $25K | 0.01% |
+388
| New | +$24.5K |
2026 Q2
0 quarters
|
|
203
Truist Financial
TFC
$59.8B
| $24.8K | 0.01% |
+498
| New | +$24.5K |
2026 Q2
0 quarters
|
|
204
Rexford Industrial Realty
REXR
$7.98B
| $24.8K | 0.01% |
+740
| New | +$25.9K |
2026 Q2
0 quarters
|
|
|
205
eBay
EBAY
$52.7B
| $24K | 0.01% |
215
-33,776
| -99% | -$3.6M |
2025 Q3
3 quarters
|
|
206
Generate Biomedicines
GENB
$1.61B
| $23.3K | 0.01% |
+1,384
| New | +$18.9K |
2026 Q2
0 quarters
|
|
207
Franklin Templeton
BEN
$18.4B
| $23.3K | 0.01% |
+700
| New | +$21K |
2026 Q2
0 quarters
|
|
208
J.M. Smucker
SJM
$14.1B
| $23.1K | 0.01% |
205
| – | – |
2025 Q2
4 quarters
|
|
209
Arthur J. Gallagher & Co
AJG
$71.1B
| $23K | 0.01% |
+100
| New | +$21.2K |
2026 Q2
0 quarters
|
|
210
DuPont de Nemours
DD
$20.5B
| $22.5K | 0.01% |
+166
| New | +$23.6K |
2026 Q2
0 quarters
|
|
211
Dover
DOV
$27.9B
| $22.4K | 0.01% |
+100
| New | +$21.8K |
2026 Q2
0 quarters
|
|
212
PG&E
PCG
$28.6B
| $22.2K | 0.01% |
1,316
+897
| +214% | +$15.1K |
2026 Q1
1 quarter
|
|
213
Progressive
PGR
$136B
| $21.8K | 0.01% |
+100
| New | +$20.2K |
2026 Q2
0 quarters
|
|
214
Old Dominion Freight Line
ODFL
$35.4B
| $21.7K | 0.01% |
100
-100
| -50% | -$21.6K |
2026 Q1
1 quarter
|
|
215
Boeing
BA
$136B
| $21.6K | 0.01% |
+100
| New | +$22.2K |
2026 Q2
0 quarters
|
|
216
Altria Group
MO
$130B
| $21.5K | 0.01% |
+299
| New | +$20.9K |
2026 Q2
0 quarters
|
|
217
Cooper Companies
COO
$11.8B
| $21.5K | 0.01% |
300
-300
| -50% | -$19.6K |
2026 Q1
1 quarter
|
|
218
NextEra Energy
NEE
$179B
| $21.2K | 0.01% |
+242
| New | +$21.9K |
2026 Q2
0 quarters
|
|
219
Global Payments
GPN
$23.3B
| $21.2K | 0.01% |
+299
| New | +$20.6K |
2026 Q2
0 quarters
|
|
220
The Kraft Heinz Company
KHC
$29B
| $21.1K | 0.01% |
+897
| New | +$20.7K |
2026 Q2
0 quarters
|
|
221
Ventas
VTR
$47.4B
| $21.1K | 0.01% |
238
-35,065
| -99% | -$2.99M |
2026 Q1
1 quarter
|
|
222
Bio-Techne
TECH
$11.4B
| $20.6K | 0.01% |
+299
| New | +$16.1K |
2026 Q2
0 quarters
|
|
223
McCormick & Company Non-Voting
MKC
$12.5B
| $20.2K | 0.01% |
+399
| New | +$19.6K |
2026 Q2
0 quarters
|
|
224
TKO Group
TKO
$14.1B
| $20.1K | 0.01% |
+100
| New | +$19.5K |
2026 Q2
0 quarters
|
|
225
Capital One
COF
$116B
| $20.1K | 0.01% |
+100
| New | +$19.1K |
2026 Q2
0 quarters
|
|
Similar funds
TM
Stance Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Stance Capital held 426 positions worth $328M, up 59% from $206M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Stance Capital deployed $83.8M of net new capital in Q2 2026, opening 146 new positions and adding to 72 existing holdings. Its largest new stake was Rollins: 88,929 shares worth $3.71M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $4.36M trimmed.
- Stance Capital's largest Q2 2026 buy was Rollins: 88,929 shares worth $3.71M.
- Stance Capital added most to Comcast in Q2 2026, an estimated $3.72M increase.
- Stance Capital's biggest Q2 2026 reduction was Bristol-Myers Squibb, cutting an estimated $4.36M.
- Stance Capital fully exited Bank of New York Mellon in Q2 2026, selling an estimated $1.43M.
- Stance Capital's ten largest holdings make up 22% of its $328M portfolio in Q2 2026.
- Stance Capital opened 146 new positions and closed 86 in Q2 2026.
- Stance Capital's portfolio value rose 59% quarter-over-quarter to $328M.
Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.